by GlobeNewsWire | Aug 26, 2015 | Biotech, Client News, Globe Newswire, Health, Medical Stocks
SAN FRANCISCO and GENEVA, Aug. 26, 2015 (GLOBE NEWSWIRE) — Amarantus BioScience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing therapeutic and diagnostic product candidates in orphan indications and neurology, announced that its 2015 Annual...
by editor | Oct 14, 2014 | Profile
StockGuru Spotlight on Amarantus Bioscience Holdings, Inc.(Symbol: AMBS) Help us update information on this company. Email any updates to: [email protected] About Amarantus Bioscience Holdings, Inc.: Amarantus BioScience Holdings (AMBS) is a biotechnology company...
by editor | Aug 2, 2014 | Blog, Featured, Top, Trade Alert
We are announcing our Break-out Stocks for August. The reason we have chosen these varies from one stock to another. That said, we are looking at each of these to make a material move in August in a positive upside that investors can take advantage of. You will note...
by editor | Jul 23, 2014 | Alert, Blog, Featured, Medical Stocks, Success, Top, Trade Alert, Update
Amarantus BioScience Holdings (OTCQB: AMBS) is up on volume crossing over four million shares at midday. This follows our alert overnight that included the most recent news the company issued: Amarantus BioScience Holdings $AMBS Announces Greenwood to Key Industry...
by editor | Jul 23, 2014 | Blog, Breaking News, Featured, Medical Stocks, Top, Update
Amarantus and BSI Proudly Announce BIO CEO & President Jim Greenwood as Panelist for 3rd Alzheimer’s Focused #C4CT Concussion Awareness Summit at United Nations Brewer Sports International (BSI), a multi-faceted global sports advisory firm, and Amarantus...